Skin Rejuvenation Technologies (Proprietary) Limited – Trademark Portfolio
Entity Type: 11
Skin Rejuvenation Technologies (Proprietary) Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OPTIPHI. The owner is based in Irene, Gauteng.
Southern Implants Office Park
Building 10, 1 Albert Road
Irene, Gauteng 1675 , ZA
Showing of trademarks Trademarks
Trademark Classifications
Skin Rejuvenation Technologies (Proprietary) Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Skin Rejuvenation Technologies (Proprietary) Limited have?
Skin Rejuvenation Technologies (Proprietary) Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Skin Rejuvenation Technologies (Proprietary) Limited file in?
Skin Rejuvenation Technologies (Proprietary) Limited files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Skin Rejuvenation Technologies (Proprietary) Limited's most well-known trademarks?
Skin Rejuvenation Technologies (Proprietary) Limited's registered trademark portfolio includes well-known marks such as OPTIPHI. These are among 1 currently registered trademark in the portfolio.
What is Skin Rejuvenation Technologies (Proprietary) Limited's trademark registration success rate?
Skin Rejuvenation Technologies (Proprietary) Limited has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.